Device Week, April 26, 2018 – On Patent Rulings And New Reimbursement Rates

In this edition of Device Week, Tina Tan chats to Elizabeth Orr on recent patent rulings, one related to an ongoing battle between TAVR rivals Boston Scientific and Edwards Lifesciences and another related to the broader area of challenging patent judgements. She also speaks to David Filmore to find out more details about CMS’s annual hospital inpatient proposal which it has just issued and how the new reimbursement rates would impact industry. For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Here are a couple of other Medtech Insight articles related to patent rulings and reimbursement: Boston Sci Wins Latest TAVR Patent Dispute Against Edwards https://protect-us.mimecast.com/s/ZLUJCgJxkgiAGxZMgHyZzZ1?domain=medtech.pharmaintelligence.informa.com Orthopedists Asked CMS To Stop Mandatory Bundled-Pay Models https://protect-us.mimecast.com/s/8M--CjRvnlfnRMQW6SY1Le1?domain=medtech.pharmaintelligence.informa.com